Latest HIV infection Stories

Antiretroviral therapy does not affect resting energy expenditure among women with HIV, according to Journal of the Academy of Nutrition and Dietetics report Studies have shown that about 10 percent of men infected with human immunodeficiency virus (HIV) have an elevated resting energy expenditure (REE). Their bodies use more kilocalories for basic functions including circulation, body temperature, and breathing. Most studies have been conducted in men and those with solely women have had...

redOrbit Staff & Wire Reports – Your Universe Online Administering early treatment shortly after HIV infection could lead to a so-called functional cure in approximately one out of every 10 patients infected with the virus that causes AIDS, according to a new study published in the journal PLoS Pathogens. Lead researcher Asier Sáez-Cirión of the Institut Pasteur in Paris and colleagues discovered that 14 patients who were treated within the first two months following infection...

Studies suggest new approach to treating HIV A team of researchers based at Johns Hopkins has decoded a system that makes certain types of immune cells impervious to HIV infection. The system's two vital components are high levels of a molecule that becomes embedded in viral DNA like a code written in invisible ink, and an enzyme that, when it reads the code, switches from repairing the DNA to chopping it up into unusable pieces. The researchers, who report the find in the Jan. 21 early...

A 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need for long term treatment, according to research published today in the New England Journal of Medicine. However, the delay was only marginally longer than the time already spent on treatment. The study, the largest clinical trial ever undertaken looking at treating people with recent HIV infection, also suggests that the treatment lowers the...

RARITAN, N.J., Nov. 29, 2012 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced their intention not to enforce the patents they own and control on the antiretroviral (ARV) drug darunavir provided the darunavir product is medically acceptable and is used only in resource-limited settings.(1) This announcement is intended to assure generic manufacturers that they may manufacture high quality darunavir product used in SSA and the LDCs without...

Novel method could help advance the fight against persistent 'HIV latency' Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS. In a paper being published online today in Lab on a Chip, the laboratory of Gladstone Investigator Leor Weinberger, PhD, announced the...

Study finds HIV home test is popular among men with high risk sexual practices Thirty years into the HIV epidemic, many people who are at high risk of HIV infection cannot or will not adopt safer sexual practices, such as abstinence and condom use.  This means there is room in the market for alternative methods to reduce either exposure to or transmission of HIV among these individuals.  One such strategy, HIV home testing (HT), is the subject of a recent study by Alex Carballo-Dieguez...

Study results released today by the HIV Prevention Trials Network (HPTN) show disturbing rates of new HIV infections occurring among black gay and bisexual men in the U.S. (also known as men who have sex with men, or MSM), particularly young black MSM. The HPTN 061 study showed that the overall rate of new HIV infection among black MSM in this study was 2.8% per year, a rate that is nearly 50% higher than in white MSM in the U.S. Even more alarming, HPTN 061 found that young black MSM—those...

RESEARCH TRIANGLE PARK, N.C., July 23, 2012 /PRNewswire-USNewswire/ -- Study results released today by the HIV Prevention Trials Network (HPTN) show disturbing rates of new HIV infections occurring among black gay and bisexual men in the U.S. (also known as men who have sex with men, or MSM), particularly young black MSM. The HPTN 061 study showed that the overall rate of new HIV infection among black MSM in this study was 2.8% per year, a rate that is nearly 50% higher than in white...

Safety, tolerability study to enroll MSM in the United States and Puerto Rico Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection. The trial involves a strategy known as...